Literature DB >> 10752536

Proximal tubular cysts in fetal human autosomal recessive polycystic kidney disease.

Koichi Nakanishi1, William E Sweeney1, Klaus Zerres2, Lisa M Guay-Woodford3, Ellis D Avner1.   

Abstract

Standard texts describe human autosomal recessive polycystic kidney disease (ARPKD) as a cystic kidney disease in which lesions are localized to collecting tubules. Murine models of ARPKD consistently demonstrate an early phase of proximal tubular (PT) cystic involvement, which disappears shortly after birth. This is followed by a phase of collecting tubular (CT) cyst formation and progressive enlargement leading to compromise of renal function and death. Because the description of cystic lesions in human ARPKD has been largely based on postnatal specimens, PT cyst formation was hypothesized to be a characteristic feature of fetal human, as well as murine, ARPKD. This study examines nephron segment-specific cyst localization histochemically by lectin binding in 11 human ARPKD specimens obtained at different fetal and postnatal ages. PT cysts were found in human fetal specimens from gestational age 14 wk to 26 wk. The percentage of cysts involving PT segments ranged from 2 to 41%. The cystic index of PT cysts ranged from 2 to 5. In all specimens in which PT cysts were found, both the percentage of CT cysts and their cystic index were equal to or greater than the percentage of PT cysts and the associated PT cystic index. PT cysts were absent in all kidney specimens older than 34 wk gestational age. It is concluded that human ARPKD, like murine ARPKD, has a transient phase of PT cyst formation during early fetal development.

Entities:  

Mesh:

Year:  2000        PMID: 10752536     DOI: 10.1681/ASN.V114760

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  22 in total

1.  Synergistic Genetic Interactions between Pkhd1 and Pkd1 Result in an ARPKD-Like Phenotype in Murine Models.

Authors:  Rory J Olson; Katharina Hopp; Harrison Wells; Jessica M Smith; Jessica Furtado; Megan M Constans; Diana L Escobar; Aron M Geurts; Vicente E Torres; Peter C Harris
Journal:  J Am Soc Nephrol       Date:  2019-08-19       Impact factor: 10.121

Review 2.  New approaches to the autosomal recessive polycystic kidney disease patient with dual kidney-liver complications.

Authors:  Grzegorz Telega; David Cronin; Ellis D Avner
Journal:  Pediatr Transplant       Date:  2013-04-17

3.  Mutations in DZIP1L, which encodes a ciliary-transition-zone protein, cause autosomal recessive polycystic kidney disease.

Authors:  Hao Lu; Maria C Rondón Galeano; Elisabeth Ott; Geraldine Kaeslin; P Jaya Kausalya; Carina Kramer; Nadina Ortiz-Brüchle; Nadescha Hilger; Vicki Metzis; Milan Hiersche; Shang Yew Tay; Robert Tunningley; Shubha Vij; Andrew D Courtney; Belinda Whittle; Elke Wühl; Udo Vester; Björn Hartleben; Steffen Neuber; Valeska Frank; Melissa H Little; Daniel Epting; Peter Papathanasiou; Andrew C Perkins; Graham D Wright; Walter Hunziker; Heon Yung Gee; Edgar A Otto; Klaus Zerres; Friedhelm Hildebrandt; Sudipto Roy; Carol Wicking; Carsten Bergmann
Journal:  Nat Genet       Date:  2017-05-22       Impact factor: 38.330

4.  Transforming growth factor alpha (TGF-alpha) and other targets of tumor necrosis factor-alpha converting enzyme (TACE) in murine polycystic kidney disease.

Authors:  Raghad Nemo; Noel Murcia; Katherine Macrae Dell
Journal:  Pediatr Res       Date:  2005-03-17       Impact factor: 3.756

5.  Generation of Human PSC-Derived Kidney Organoids with Patterned Nephron Segments and a De Novo Vascular Network.

Authors:  Jian Hui Low; Pin Li; Elaine Guo Yan Chew; Bingrui Zhou; Keiichiro Suzuki; Tian Zhang; Michelle Mulan Lian; Meng Liu; Emi Aizawa; Concepcion Rodriguez Esteban; Kylie Su Mei Yong; Qingfeng Chen; Josep M Campistol; Mingliang Fang; Chiea Chuen Khor; Jia Nee Foo; Juan Carlos Izpisua Belmonte; Yun Xia
Journal:  Cell Stem Cell       Date:  2019-07-11       Impact factor: 24.633

6.  Incompletely penetrant PKD1 alleles mimic the renal manifestations of ARPKD.

Authors:  Mihailo Vujic; Christina M Heyer; Elisabet Ars; Katharina Hopp; Arseni Markoff; Charlotte Orndal; Bengt Rudenhed; Samih H Nasr; Vicente E Torres; Roser Torra; Nadja Bogdanova; Peter C Harris
Journal:  J Am Soc Nephrol       Date:  2010-06-17       Impact factor: 10.121

7.  A novel model of autosomal recessive polycystic kidney questions the role of the fibrocystin C-terminus in disease mechanism.

Authors:  Patricia Outeda; Luis Menezes; Erum A Hartung; Stacey Bridges; Fang Zhou; Xianjun Zhu; Hangxue Xu; Qiong Huang; Qin Yao; Feng Qian; Gregory G Germino; Terry Watnick
Journal:  Kidney Int       Date:  2017-07-18       Impact factor: 10.612

8.  Functional polycystin-1 dosage governs autosomal dominant polycystic kidney disease severity.

Authors:  Katharina Hopp; Christopher J Ward; Cynthia J Hommerding; Samih H Nasr; Han-Fang Tuan; Vladimir G Gainullin; Sandro Rossetti; Vicente E Torres; Peter C Harris
Journal:  J Clin Invest       Date:  2012-10-15       Impact factor: 14.808

9.  Mutations in zebrafish leucine-rich repeat-containing six-like affect cilia motility and result in pronephric cysts, but have variable effects on left-right patterning.

Authors:  Fabrizio C Serluca; Bo Xu; Noriko Okabe; Kari Baker; Shin-Yi Lin; Jessica Sullivan-Brown; David J Konieczkowski; Kimberly M Jaffe; Joshua M Bradner; Mark C Fishman; Rebecca D Burdine
Journal:  Development       Date:  2009-05       Impact factor: 6.868

10.  Zebrafish mutations affecting cilia motility share similar cystic phenotypes and suggest a mechanism of cyst formation that differs from pkd2 morphants.

Authors:  Jessica Sullivan-Brown; Jodi Schottenfeld; Noriko Okabe; Christine L Hostetter; Fabrizio C Serluca; Stephan Y Thiberge; Rebecca D Burdine
Journal:  Dev Biol       Date:  2007-12-03       Impact factor: 3.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.